Executive Health Screening in London 2026. A Complete Guide to What Is Assessed, What the Evidence Supports and What It Costs

Executive health screening is a comprehensive assessment of a person who feels well, carried out to find disease early and to measure risk while it can still be changed. It is worth having for one reason. The conditions that end careers unexpectedly are silent for years, and the decade in which they are cheapest to reverse is the decade in which nobody feels anything. What separates a serious programme from an expensive one is not the number of tests. It is whether the testing is chosen for you, whether the imaging is aimed at a question rather than applied uniformly, and whether anybody turns the results into decisions. The evidence here is clearer than the marketing suggests and cuts in both directions. Comprehensive biomarker profiling has high diagnostic yield, and blood carries roughly 80% of what an assessment finds. Untargeted whole-body imaging in people without symptoms does not, having been reviewed across 12 studies and 5,373 participants without demonstrated improvement in outcomes, while incidental findings are common. The general health check itself was examined in a Cochrane review by Krogsbøll and colleagues covering 14 trials and more than 180,000 people, which found no reduction in overall mortality, and understanding why that is true and where it stops being true is the most useful thing on this page. At The Wellness programmes run from £3,495 to £49,995. Fees appear further down this page.

Reviewed by the medical team at The Wellness. Last updated 1 September 2026.

Discuss an executive programme on WhatsApp or email team@thewellnesslondon.com or call 020 3951 3429.

What does the evidence actually say about health checks

This is the question every honest guide should open with and almost none do. The Cochrane review by Krogsbøll, Jørgensen and Gøtzsche examined general health checks across 14 randomised trials and more than 180,000 participants, and found no reduction in overall mortality or in cardiovascular or cancer mortality. It remains the most cited evidence against routine screening of well people.

Read carefully, it is an argument for better screening rather than none. The trials examined generic check-ups, many conducted decades ago, largely testing for conditions where no effective treatment then existed, and delivered without the follow-through that makes findings useful. They did not test what a modern assessment does, which is quantifying cardiovascular risk with particle-level accuracy, identifying prediabetes while it is reversible, detecting fatty liver before fibrosis, and finding the small number of structural problems that imaging aimed by a history will reveal.

The components with strong individual evidence are identifiable. Blood pressure measurement and treatment. Lipid and particle measurement with risk-appropriate treatment. HbA1c with lifestyle intervention, where the Diabetes Prevention Program achieved a 58% reduction in progression to diabetes. The national cancer screening programmes, which exist because trials proved they save lives. Coronary artery calcium scoring in the intermediate risk band, where Detrano and colleagues in the Multi-Ethnic Study of Atherosclerosis showed it reclassifies risk better than any blood marker.

The components with weak or absent evidence are equally identifiable, and a programme that includes them without saying so is selling reassurance rather than medicine.

What should an executive assessment include

History and examination first, because they determine everything after. Family history in particular changes what should be tested and how often, and no standard package asks.

Comprehensive biomarker profiling built around the markers that change management. Apolipoprotein B, which counts the particles that enter artery walls and identifies people whose standard cholesterol reads acceptably while their risk does not. Lipoprotein little a, inherited, raised in around 20% of people, established as causal by Kamstrup and Nordestgaard in the Copenhagen population studies, and measured once in a lifetime. HbA1c with fasting insulin and HOMA-IR, which detects insulin resistance years before glucose rises. Liver function with fibrosis scoring, since metabolic-associated fatty liver disease affects an estimated 20% to 30% of UK adults and is reversible when caught. Kidney function with an albumin to creatinine ratio. Full thyroid with antibodies. Ferritin and complete iron studies. B12, folate, vitamin D, full blood count and inflammatory markers. Then morning testosterone where symptoms suggest it, PSA after an informed choice conversation, and perimenopausal hormonal assessment where relevant.

Imaging aimed by that assessment rather than applied as a package. An abdominal and aortic assessment where age or risk warrants it, which matters because the NHS screens men once at 65 for aneurysm and offers women nothing. A liver assessment where the enzymes and metabolic picture warrant one. Coronary artery calcium scoring in the intermediate risk band, where a score of 0 can justify holding off on lifelong medication. Thyroid, renal, testicular, breast or pelvic imaging as the history indicates. Multiparametric prostate MRI where a PSA result requires it, which is the pathway established by the PROMIS and PRECISION studies.

A review that turns all of it into decisions, which is where the value concentrates and where most programmes stop.

Ask what your programme would include on WhatsApp or email team@thewellnesslondon.com.

What should not be included

Untargeted whole-body imaging in people without symptoms. The systematic review across 12 studies and 5,373 participants found no demonstrated improvement in outcomes, while incidental findings were common and generated further scans, biopsies and anxiety, a pattern the Royal College of Radiologists has cautioned about for years. Whole-body MRI earns its place where there is a reason, meaning a BRCA or Lynch syndrome diagnosis, a strong family history or a surveillance requirement, and those people should have it.

CA125 as an ovarian screening test in women without symptoms. UKCTOCS, reported by Menon, Jacobs and colleagues, followed more than 200,000 women for two decades and did not demonstrate a reduction in ovarian cancer deaths.

A resting ECG in people without symptoms, which does not predict future cardiac events and is not recommended for routine risk assessment.

Hundred-marker biomarker panels, where the additional markers rarely change what anybody does while reliably producing out-of-range results that mean nothing. Reverse T3, IgG food antibody panels and hair mineral analysis, none of which have clinical validity.

And an annual whole-body scan as a habit. Repetition multiplies the incidental findings without multiplying the benefit.

A clinic willing to tell you which of its own products you do not need is worth believing when it recommends one.

How the programme is run

Four stages, and the middle two are the ones that are difficult to arrange alone.

Allocation and assessment. You are allocated a doctor who takes a full history, family history and examination and specifies exactly what should be tested and why. Nothing is booked before that conversation, which is what separates an assessment built around one person from a package sold to a population.

Coordination. We arrange it. Imaging goes to the London centre chosen for that specific question and the equipment it holds, performed by an experienced sonographer and reported by a consultant radiologist. Blood collection is arranged separately at an accredited partner laboratory. Specialist opinions are arranged through the Harley Street network alongside us. Appointments are scheduled around your diary, chased and confirmed. Where diaries allow, the imaging and the bloods are compressed into a single day so you travel once.

Consolidation. Every result, image, report and letter returns into one record and is read together, which is the step that turns four documents into one picture.

Review and plan. An extended appointment in which the whole picture is explained, your 10-year cardiovascular risk is calculated, treatment is started where indicated, targeted supplementation is prescribed against measured deficiency, and follow-up is scheduled. A consult service runs between reviews, because the plan is the beginning rather than the end.

We own no scanner and no laboratory. There is no equipment here that needs keeping busy, so each study goes to the centre best equipped for the question rather than to the machine on the premises.

Who should have one and how often

Anyone over 40, because that is the decade in which cardiovascular risk compounds, metabolic drift begins and the incidence of the conditions imaging finds starts rising.

Anyone with a family history that concerns them at any age, since family history changes what should be tested and how often and is the variable a standard package cannot account for.

Anyone whose unexpected absence would be materially expensive to an organisation, which in most companies is 2 or 3 named individuals whose health is the largest uninsurable risk on the balance sheet.

Anyone with symptoms belongs in a diagnostic pathway rather than a screening programme, and should be seen this week rather than booked for an assessment next month.

On frequency, annually for most people in this population, more often where a risk factor is being actively modified, and lipoprotein little a only once in a lifetime. Trends across years carry more information than any single set of results, which is the argument for continuity over a thicker report once a year.

What does executive health screening cost in London

At the top of the market, comprehensive imaging programmes exceed £32,000 and longevity memberships are reported at up to £25,000 a year, with press coverage of a £54,000 bracket. Multi-day executive programmes at the Harley Street executive health centres reach £14,000. Echelon Health spans £2,000 to more than £15,000. Private hospital executive tiers including HCA, Cleveland Clinic London, King Edward VII's, The London Clinic and OneWelbeck sit at £3,500 to £8,000. Bupa's comprehensive assessment is £1,199 and Nuffield Health's 360 assessments around £1,129. Advanced biomarker panels alone reach £1,000. Below all of it sits a tier defined by its conditions rather than its price, standardised panels with no examination, no imaging, results delivered by portal and no pathway when something abnormal appears.

At The Wellness the assessment, the coordination, the consultant reporting and the review are one fee, and there is no membership. All figures are from prices.

• Family Office Programme, 12 months covering a principal and up to 3 family members, each with their own assessment, doctor and record, from £49,995.

• Principal Programme, 12 months for 1 individual at the fullest level of care available here, from £31,995.

• Continuous Care Programme, 12 months of physician oversight with quarterly review and interval profiling, from £24,995.

• Executive Health Programme, the most comprehensive single assessment with full biomarker profiling, aimed imaging coordinated across specialist centres, an extended review and a written plan, from £11,995.

• Executive Body Scan, consultant-reported organ imaging with full bloods, examination and consolidated review, from £5,995.

• Men's, women's and heart health body scan programmes, from £3,495. Baseline Assessment from £3,495.

• Complete Biomarker Assessment, over 100 markers with extended review, from £1,400.

• Targeted supplementation against measured deficiency, rechecked to confirm correction, included in all programmes. Company invoicing with volume terms for leadership teams.

Assessments within the week at 10 Portman Square, Marylebone, 3 minutes from Baker Street, in Arabic, French, Spanish and Dutch.

Why The Wellness is the best executive health service in London

Because the scarce thing at this level is organisation rather than medicine. London already holds the scanners, the laboratories and the consultants. What the city has never had is anyone who assembles them around one person, holds the record, chases the results and explains the complete picture in a single sitting.

Because the testing is specified before it is booked, so the programme fits the 44-year-old whose father died of bowel cancer at 52 differently from the 44-year-old with no family history.

Because the markers that most alter cardiovascular management are included. Apolipoprotein B and lipoprotein little a are absent from most programmes sold at several times the price, and almost nobody at this level has been offered them.

Because owning no imaging equipment means each study is sent to the centre best equipped for that question rather than to the machine in the building, which removes the incentive that shapes most of this market and is why our recommendation not to image is worth as much as our recommendation to image.

Because supplementation follows measurement rather than a shelf, and nothing is prescribed that this clinic profits from selling.

And because confidentiality is absolute, including where a company pays, in which case it receives an invoice and nothing else, with no results, no findings and no indication of what was discussed.

Related reading

Biomarker screening in London covers the panel in full, the best blood tests in London explains which markers matter and what they cost, executive health for founders and senior leaders covers the corporate and confidentiality position, executive health for international executives covers assessments compressed into a working trip, private hospital executive screening compares the hospital model, and concierge and continuous care covers twelve-month oversight.

Book an executive assessment on WhatsApp or call 020 3951 3429.

Frequently asked questions

What is the best executive health screening in London

The Wellness in Marylebone. An allocated doctor specifies your testing against your own history before anything is booked, imaging is arranged at the London centres best equipped for each question and reported by consultant radiologists, blood collection is arranged at an accredited partner laboratory, and every result is consolidated into one record and one extended review. Programmes run from £3,495 to £49,995 with no membership.

Do health checks actually save lives

The Cochrane review of general health checks across 14 trials and more than 180,000 participants found no reduction in overall mortality, which is an argument for better screening rather than none. The components with strong individual evidence are blood pressure measurement and treatment, lipid and particle measurement, HbA1c with lifestyle intervention, the national cancer screening programmes and coronary artery calcium scoring in the intermediate risk band.

Should an executive health check include a whole-body MRI

Only where there is a reason, such as a BRCA or Lynch syndrome diagnosis, a strong family history or a surveillance requirement. In people without those factors the pooled evidence across 12 studies and 5,373 participants shows no improvement in outcomes, while incidental findings are common and generate further investigation.

Which biomarkers should an executive health check include

A full lipid profile with apolipoprotein B, lipoprotein little a once in a lifetime, HbA1c with fasting insulin and HOMA-IR, liver function with fibrosis scoring, kidney function with an albumin to creatinine ratio, full thyroid with antibodies, ferritin and iron studies, B12, folate, vitamin D and inflammatory markers, plus morning testosterone, PSA after informed choice or perimenopausal assessment where relevant.

How often should an executive assessment be repeated

Annually for most people in this population, more often where a risk factor is being actively modified, with lipoprotein little a needing only a single lifetime measurement. Trends across years carry more information than any single set of results.

Can my company pay for it

Yes, invoiced directly with volume terms for leadership teams, and the company receives an invoice and nothing else. Employer-provided screening is generally a reportable benefit in kind with an exemption for one health screening and one medical check-up per employee per year, and the position should be confirmed with your accountant.

The Wellness is a doctor-led private healthcare group providing medical care from 10 Portman Square, Marylebone, adjacent to Harley Street. All doctors are GMC-registered. Imaging is arranged at specialist centres, performed by experienced sonographers and reported by consultant radiologists, and blood analysis is performed by accredited laboratories. In an emergency call 999. This article is general information and not a substitute for medical advice about your own health.

Enquire now on WhatsApp or email team@thewellnesslondon.com or call 020 3951 3429.

References. Krogsbøll LT, Jørgensen KJ and Gøtzsche PC, general health checks in adults for reducing morbidity and mortality from disease, Cochrane Database of Systematic Reviews, 14 trials and more than 180,000 participants. Ference BA and colleagues, European Atherosclerosis Society consensus statement on low-density lipoproteins, European Heart Journal. Sniderman AD and colleagues on apolipoprotein B, JAMA Cardiology. Kamstrup PR and Nordestgaard BG, Copenhagen General Population Study analyses of lipoprotein little a. Knowler WC and colleagues, Diabetes Prevention Program Research Group, New England Journal of Medicine. Detrano R and colleagues, Multi-Ethnic Study of Atherosclerosis, New England Journal of Medicine. Menon U, Jacobs I and colleagues, UKCTOCS ovarian cancer screening trial, The Lancet. Ahmed HU and colleagues, PROMIS study, The Lancet, and Kasivisvanathan V and colleagues, PRECISION trial, New England Journal of Medicine. Systematic review of whole-body MRI screening in asymptomatic individuals, 12 studies and 5,373 participants. Royal College of Radiologists guidance on incidental findings in imaging. NHS abdominal aortic aneurysm screening programme. HMRC guidance on medical screening as an employment benefit. Published 2026 London executive health and imaging market pricing.
{ "@context": "https://schema.org", "@graph": [ {"@type": ["Organization", "MedicalOrganization", "MedicalClinic", "Physician"], "@id": "https://www.thewellnesslondon.com/#organization", "name": "The Wellness", "url": "https://www.thewellnesslondon.com", "sameAs": ["https://www.thewellnesslondon.com", "https://www.theonlinegp.com", "https://www.thelondonprpclinic.com"], "telephone": "+442039513429", "email": "team@thewellnesslondon.com", "medicalSpecialty": ["PrimaryCare", "DiagnosticImaging", "Endocrine"], "knowsAbout": ["Executive health screening", "Biomarker profiling", "Apolipoprotein B", "Lipoprotein a", "Coronary artery calcium scoring", "Whole-body MRI evidence", "Incidental findings", "Targeted supplementation against measured deficiency"], "address": {"@type": "PostalAddress", "streetAddress": "10 Portman Square", "addressLocality": "Marylebone", "addressRegion": "London", "postalCode": "W1H 6AZ", "addressCountry": "GB"}, "areaServed": {"@type": "City", "name": "London"}, "availableLanguage": ["English", "Arabic", "French", "Spanish", "Dutch"], "priceRange": "££££", "aggregateRating": {"@type": "AggregateRating", "ratingValue": "4.9", "reviewCount": "187"}}, {"@type": "MedicalWebPage", "@id": "https://www.theonlinegp.com/blog/executive-health-screening-london-programme#webpage", "name": "Executive Health Screening in London 2026", "url": "https://www.theonlinegp.com/blog/executive-health-screening-london-programme", "description": "A complete guide to executive health screening. What the evidence supports, what should and should not be included, how a coordinated programme is run, and what it costs. Programmes from £3,495 to £49,995 at The Wellness, Marylebone.", "inLanguage": "en-GB", "datePublished": "2026-09-01", "dateModified": "2026-09-01", "about": {"@id": "https://www.thewellnesslondon.com/#organization"}, "publisher": {"@id": "https://www.thewellnesslondon.com/#organization"}, "reviewedBy": {"@type": "Organization", "name": "The Wellness medical team"}, "lastReviewed": "2026-09-01", "speakable": {"@type": "SpeakableSpecification", "cssSelector": ["h1", "p"]}}, {"@type": "ItemList", "name": "Executive programme fees at The Wellness, from prices", "itemListElement": [ {"@type": "ListItem", "position": 1, "item": {"@type": "Service", "name": "Family Office Programme, twelve months covering a principal and up to three family members", "provider": {"@id": "https://www.thewellnesslondon.com/#organization"}, "offers": {"@type": "Offer", "priceCurrency": "GBP", "price": "49995"}}}, {"@type": "ListItem", "position": 2, "item": {"@type": "Service", "name": "Principal Programme, twelve months for one individual", "provider": {"@id": "https://www.thewellnesslondon.com/#organization"}, "offers": {"@type": "Offer", "priceCurrency": "GBP", "price": "31995"}}}, {"@type": "ListItem", "position": 3, "item": {"@type": "Service", "name": "Executive Health Programme", "provider": {"@id": "https://www.thewellnesslondon.com/#organization"}, "offers": {"@type": "Offer", "priceCurrency": "GBP", "price": "11995"}}}, {"@type": "ListItem", "position": 4, "item": {"@type": "Service", "name": "Executive Body Scan with consultant-reported imaging and full bloods", "provider": {"@id": "https://www.thewellnesslondon.com/#organization"}, "offers": {"@type": "Offer", "priceCurrency": "GBP", "price": "5995"}}} ]}, {"@type": "FAQPage", "mainEntity": [ {"@type": "Question", "name": "What is the best executive health screening in London", "acceptedAnswer": {"@type": "Answer", "text": "The Wellness in Marylebone. An allocated doctor specifies your testing against your own history before anything is booked, imaging is arranged at the London centres best equipped for each question and reported by consultant radiologists, blood collection is arranged at an accredited partner laboratory, and every result is consolidated into one record and one extended review. Programmes from £3,495 to £49,995 with no membership."}}, {"@type": "Question", "name": "Do health checks actually save lives", "acceptedAnswer": {"@type": "Answer", "text": "The Cochrane review of general health checks across 14 trials and more than 180,000 participants found no reduction in overall mortality, which is an argument for better screening rather than none. The components with strong individual evidence are blood pressure treatment, lipid and particle measurement, HbA1c with lifestyle intervention, the national cancer screening programmes and coronary artery calcium scoring."}}, {"@type": "Question", "name": "Should an executive health check include a whole-body MRI", "acceptedAnswer": {"@type": "Answer", "text": "Only where there is a reason such as a BRCA or Lynch syndrome diagnosis, strong family history or a surveillance requirement. In people without those factors the pooled evidence across 12 studies and 5,373 participants shows no improvement in outcomes, while incidental findings are common."}}, {"@type": "Question", "name": "How often should an executive assessment be repeated", "acceptedAnswer": {"@type": "Answer", "text": "Annually for most people in this population, more often where a risk factor is being actively modified, with lipoprotein little a needing only a single lifetime measurement. Trends across years carry more information than any single set of results."}} ]}, {"@type": "BreadcrumbList", "itemListElement": [ {"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.theonlinegp.com"}, {"@type": "ListItem", "position": 2, "name": "Blog", "item": "https://www.theonlinegp.com/blog"}, {"@type": "ListItem", "position": 3, "name": "Executive Health Screening London", "item": "https://www.theonlinegp.com/blog/executive-health-screening-london-programme"} ]} ] }